Chorioallantoic membrane

Chorioallantoic membrane
The chorioallantoic membrane of a developing chick covered with Smallpox virus pocks
Identifiers
MeSHD049033
Anatomical terminology

The Chorioallantoic Membrane (CAM), also known as the chorioallantois, is a highly vascularized membrane found in the eggs of certain amniotes like birds and reptiles. It is formed by the fusion of the mesodermal layers of two extra-embryonic membranes – the chorion and the allantois.[1] It is the avian homologue of the mammalian placenta. It is the outermost extra-embryonic membrane which lines the non-vascular egg shell membrane.

Structure

The chorioallantoic membrane is composed of three layers. The first is the chorionic epithelium that is the external layer present immediately below the shell membrane.[2] It consist of epithelial cells that arise from chorionic ectoderm. The second is the intermediate mesodermal layer that consists of mesenchymal tissue formed by the fusion of the mesodermal layer of the chorion and the mesodermal layer of the allantois. This layer is highly vascularized and rich in stromal components. The third is the allantoic epithelium that consists of epithelial cells arising from the allantoic ectoderm. It forms a part of the wall of the allantoic sac.

Both the epithelial layers are separated from the mesodermal layer by basement membranes.[3]

Function

The Chorioallantoic membrane performs the following functions:

The CAM functions as the site of gaseous exchange for oxygen and carbon dioxide between the growing embryo and the environment. Blood capillaries and sinuses are found in the intermediate mesodermal layer allows close contact (within 0.2 μm) with air found in pores of the shell membrane of the egg.[4]

The chorionic epithelial layer contains the calcium transporting region of the CAM, and thus is responsible for the transport of calcium ions from the egg shell into the embryo for the purpose of ossification of the bones of the developing embryo.[2][5] The CAM also helps in maintaining the acid-base homeostasis in the embryo.[6] Finally the allantoic epithelium serves a barrier to the allantoic cavity, and acts in a selectively permeable manner by permitting the absorption of water and electrolytes, as well as maintains a barrier against the toxins and waste materials stored inside the allantoic cavity.[2]

Development

The development of the CAM is similar to that of the allantois in mammals. Its growth starts from day 3 of embryonic development. Development of the allantois occurs extra embryonically from the ventral wall of the endodermal hindgut. Partial fusion of the chorion and allantois occurs between days 5 and 6. By day 10, there is an extensive formation of capillary network. The complete differentiation of the CAM is complete by day 13.[7][5]

Cultivation protocols

Chorioallantoic membranes can be cultivated either outside (ex-ovo) or inside of the shell (in-ovo).

Ex-ovo

Here, the embryo is grown outside of the shell. In this method, the eggs are first kept in inside a humidified incubator for up to a period of 3 days, to ensure that the position of the embryo is opposite to the position where the egg will be subsequently cracked. A small hole is made on the side of the air chamber to equilibrate the pressure, followed by the cracking of the egg on a petri-dish.[8]

This method is ideal for visualizing the growing embryo and their manipulation without limitations in accessing the embryo during the different stages of development. However the process requires aseptic conditions. There are also problems associated with the handling of the embryo, as the yolk membrane is prone to rupture both during and after the culture.[7]

In-ovo

Here, the embryo is grown within the confines of the egg shell. In this method, fertilized eggs are rotated inside an incubator for three days in order to prevent the embryo from sticking to the membranes of the shell. A hole is then created on the eggshell and wrapped with a film to prevent dehydration and infections. The egg is then maintained in a static position until further use. This step prevents the CAM from sticking to the shell membrane. At day 7 post-fertilisation, the hole is extended in order to access the CAM. [9]

This method offers several advantages over the ex-vivo method as the physiological environment for the developing embryo remains virtually unchanged. It is easier to maintain sterility as well the integrity of the CAM and the embryo when they are present inside the shell.[7] However good technical skills are required for this method. The presence of the shell around the developing embryo makes access to the embryo difficult. There are also limitations in the observing and imaging of the developing embryo.

Applications

CAM provides several features such as ease of access, and the rapid development of the membrane structure, presence of an immunodeficient environment,[10] ease of visualization for imaging techniques ranging from microscopic to PET scans.[7] Thus, it makes for a suitable model for a number of research applications in the field of biological and biomedical research:

Advantages

The advantages of using CAM are:

  •   It is easy to use as compared to other animal models.
  •  Assays can be visualized real time using very simple to highly complex visualizing techniques.[7]
  •  Rapid vascular growth.
  •  Cost effective, easy to access.
  •  The circulatory system is completely accessible making the delivery of intravenous molecules easy.
  •  Assays take relatively less time.
  •  Easily reproducible and reliable.

Disadvantages

Despite the numerous advantages, there are a number of disadvantages associated with the use CAMs:

  • Sensitivity to modifications in environmental conditions.[5]
  • Limited availability of reagents like antibodies due to avian origin.
  • Non-specific inflammatory reaction after 15 days of development.[5]
  • Difficulty of distinguishing the formation of new capillaries from the already existing vascular network.[7]
  • Differences in metabolism of drugs as compared to mammals.

References

  1. ↑ Gilbert SF (2003). Developmental biology (7th ed.). Sunderland, Mass.: Sinauer Associates. ISBN 0-87893-258-5. OCLC 51544170.
  2. 1 2 3 Gabrielli MG, Accili D (2010-03-21). "The chick chorioallantoic membrane: a model of molecular, structural, and functional adaptation to transepithelial ion transport and barrier function during embryonic development". Journal of Biomedicine & Biotechnology. 2010: 940741. doi:10.1155/2010/940741. PMC 2842975. PMID 20339524.
  3. ↑ Lusimbo WS, Leighton FA, Wobeser GA (May 2000). "Histology and ultrastructure of the chorioallantoic membrane of the mallard duck (Anas platyrhynchos)". The Anatomical Record. 259 (1): 25–34. doi:10.1002/(SICI)1097-0185(20000501)259:1<25::AID-AR3>3.0.CO;2-Y. PMID 10760740.
  4. ↑ Fáncsi T, Fehér G (June 1979). "Ultrastructural studies of chicken embryo chorioallantoic membrane during incubation". Anatomia, Histologia, Embryologia. 8 (2): 151–9. doi:10.1111/j.1439-0264.1979.tb00687.x. PMID 159001. S2CID 9045456.
  5. 1 2 3 4 Ribatti D (August 2016). "The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model". Mechanisms of Development. 141: 70–77. doi:10.1016/j.mod.2016.05.003. PMID 27178379. S2CID 7106191.
  6. ↑ Gabrielli MG (June 2004). "Carbonic anhydrases in chick extra-embryonic structures: a role for CA in bicarbonate reabsorption through the chorioallantoic membrane". Journal of Enzyme Inhibition and Medicinal Chemistry. 19 (3): 283–6. doi:10.1080/14756360410001689568. PMID 15500002. S2CID 11697041.
  7. 1 2 3 4 5 6 Nowak-Sliwinska P, Segura T, Iruela-Arispe ML (October 2014). "The chicken chorioallantoic membrane model in biology, medicine and bioengineering". Angiogenesis. 17 (4): 779–804. doi:10.1007/s10456-014-9440-7. PMC 4583126. PMID 25138280.
  8. ↑ Schomann T, Qunneis F, Widera D, Kaltschmidt C, Kaltschmidt B (2013-03-11). "Improved method for ex ovo-cultivation of developing chicken embryos for human stem cell xenografts". Stem Cells International. 2013: 960958. doi:10.1155/2013/960958. PMC 3608262. PMID 23554818.
  9. ↑ El-Ghali N, Rabadi M, Ezin AM, De Bellard ME (January 2010). "New methods for chicken embryo manipulations". Microscopy Research and Technique. 73 (1): 58–66. doi:10.1002/jemt.20753. PMC 2797828. PMID 19582831.
  10. 1 2 Endo Y (2019). "The history of the development of chick embryo tumor xenograft models". The Enzymes. Vol. 46. Elsevier. pp. 11–22. doi:10.1016/bs.enz.2019.08.005. ISBN 978-0-12-817398-5. PMID 31727272.
  11. ↑ DeBord LC, Pathak RR, Villaneuva M, Liu HC, Harrington DA, Yu W, et al. (2018). "The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research". American Journal of Cancer Research. 8 (8): 1642–1660. PMC 6129484. PMID 30210932.
  12. ↑ Mapanao, Ana Katrina; Che, Pei Pei; Sarogni, Patrizia; Sminia, Peter; Giovannetti, Elisa; Voliani, Valerio (2021-02-10). "Tumor grafted – chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation". Expert Opinion on Drug Metabolism & Toxicology: 1–22. doi:10.1080/17425255.2021.1879047. ISSN 1742-5255.
  13. ↑ Ribatti D (August 2018). "The use of the chick embryo chorioallantoic membrane as experimental model to study virus growth and to test the clonal selection hypothesis. The contribution of Sir Mac Farlane Burnet". Immunology Letters. 200: 1–4. doi:10.1016/j.imlet.2018.05.005. PMID 29886119.
  14. ↑ Guy JS (2008). "Isolation and Propagation of Coronaviruses in Embryonated Eggs". Isolation and propagation of coronaviruses in embryonated eggs. Methods in Molecular Biology. Vol. 454. pp. 109–17. doi:10.1007/978-1-59745-181-9_10. ISBN 978-1-58829-867-6. PMC 7122360. PMID 19057881.
  15. ↑ Fried B, Stableford LT (1991). "Cultivation of helminths in chick embryos". Advances in Parasitology. 30: 108–65. PMID 2069072.
  16. ↑ Sarogni, Patrizia; Mapanao, Ana Katrina; Marchetti, Sabrina; Kusmic, Claudia; Voliani, Valerio (2021-04-14). "A Standard Protocol for the Production and Bioevaluation of Ethical In Vivo Models of HPV-Negative Head and Neck Squamous Cell Carcinoma". ACS Pharmacology & Translational Science: acsptsci.1c00083. doi:10.1021/acsptsci.1c00083. ISSN 2575-9108. PMC 8205242.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.